USPH
U.S. Physical Therapy, Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Buy
+43/100
Last price
83.00
▼ 0.96 (1.14%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
84.00
Prev close
83.96
Day high
85.85
Day low
82.80
Volume
187.36K
Market cap
$1.25B
P/E (TTM)
464.61
52W range
58.19 – 93.50
Day trading desk
Gap from prior close
+0.05%
Prior close 83.96
VWAP
83.93
-1.10% from price
Relative volume
0.78×
Normal
Session range
3.68%
82.80 – 85.85
Position in range
7%
Near session low
ATR (14D)
2.18
2.62% of price
Prior day high
84.57
PDH
Prior day low
82.87
PDL
Bid / ask spread
—
Quote not published
Session volume
158.62K
Avg 203.43K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-2.93%
-4.9%
1M
+5.39%
+4.2%
3M
+19.00%
+14.5%
6M
+11.72%
-6.5%
YTD
+7.09%
-7.2%
1Y
-5.97%
-22.4%
3Y
-8.83%
-91.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on USPH open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
379.78K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 14, 26 | ETTA NCHACHA Chief Financial Officer |
STOCK | 6.83K | $0 | Direct |
| Sep 11, 26 | MINAN PETER FRANCIS Director |
BUY | 6 | $474 | Direct |
| Jun 9, 26 | MINAN PETER FRANCIS Director |
BUY | 780 | $48.78K | Direct |
| May 19, 26 | MINAN PETER FRANCIS Director |
STOCK | 2.31K | $142.07K | Direct |
| May 19, 26 | MINAN PETER FRANCIS Director |
STOCK | 2.31K | $0 | Direct |
| May 19, 26 | GILMARTIN KATHLEEN A Director |
STOCK | 2.31K | $142.07K | Direct |
| May 19, 26 | GILMARTIN KATHLEEN A Director |
STOCK | 2.31K | $0 | Direct |
| May 19, 26 | HARRIS BERNARD A. JR Director |
STOCK | 2.31K | $142.07K | Direct |
| May 19, 26 | HARRIS BERNARD A. JR Director |
STOCK | 2.31K | $0 | Direct |
| May 19, 26 | MOTSENBOCKER ANNE Director |
STOCK | 2.31K | $142.07K | Direct |
| May 19, 26 | MOTSENBOCKER ANNE Director |
STOCK | 2.31K | $0 | Direct |
| May 19, 26 | SWANSON REGG E Director |
STOCK | 2.31K | $142.07K | Direct |
| May 19, 26 | SWANSON REGG E Director |
STOCK | 2.31K | $0 | Direct |
| Mar 11, 26 | REEVE GRAHAM D Chief Operating Officer |
SELL | 662 | $52.20K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BINSTEIN RICHARD S |
General Counsel | 24.87K | Sale |
GILMARTIN KATHLEEN A |
Director | 27.09K | Stock Award(Grant) |
HARRIS BERNARD A. JR |
Director | 20.91K | Stock Award(Grant) |
HENDRICKSON CAREY P |
Chief Financial Officer | 37.81K | Stock Award(Grant) |
MOTSENBOCKER ANNE |
Director | 9.81K | Stock Award(Grant) |
READING CHRISTOPHER J |
Chief Executive Officer | 139.09K | Stock Award(Grant) |
REEVE GRAHAM D |
Chief Operating Officer | 30.08K | Sale |
SWANSON REGG E |
Director | 23.09K | Stock Award(Grant) |
TRIER CLAYTON K |
Director | 8.31K | Stock Award(Grant) |
WILLIAMS ERIC JOSEPH |
President | 40.33K | Stock Award(Grant) |
Fundamentals
Market cap$1.25B
Enterprise value$1.93B
Revenue (TTM)$804.27M
Gross profit$172.65M
EBITDA$102.01M
Net income$2.66M
EPS (TTM)$0.18
Free cash flow$41.29M
Total cash$26.26M
Total debt$385.79M
Book value / share$30.06
Shares outstanding14.92M
Float14.54M
Short % of float10.37%
Dividend yield2.20%
Beta (5Y)1.11
Valuation & profitability ratios
Trailing P/E464.61
Forward P/E24.96
PEG ratio2.75
Price / sales—
Price / book2.78
EV / revenue2.39
EV / EBITDA18.88
Gross margin21.47%
Operating margin11.13%
Profit margin4.01%
Return on equity6.51%
Return on assets4.10%
Debt / equity50.32
Current ratio1.27
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $780.99M | $671.35M | $604.80M | $553.14M | — | +16.3% |
| Operating revenue | $650.43M | $560.55M | $514.56M | $464.59M | — | +16.0% |
| Cost of revenue | $631.30M | $547.42M | $483.29M | $441.12M | — | +15.3% |
| Gross profit | $149.69M | $123.92M | $121.51M | $112.02M | — | +20.8% |
| Selling, general & admin | — | — | — | $46.11M | $46.53M | — |
| Total operating expense | $69.26M | $58.29M | $51.49M | $46.11M | — | +18.8% |
| Operating income | $80.43M | $65.63M | $70.02M | $65.91M | — | +22.6% |
| Net interest income | -$9.35M | -$4.07M | -$5.53M | -$5.78M | — | -129.6% |
| Pre-tax income | $77.81M | $60.21M | $49.38M | $55.57M | — | +29.2% |
| Tax provision | $19.81M | $14.61M | $12.16M | $12.16M | — | +35.6% |
| Net income | $15.06M | $26.46M | $14.67M | $28.27M | — | -43.1% |
| Net income to common | $21.57M | $27.73M | $18.14M | $29.26M | — | -22.2% |
| Basic EPS | 1.42 | 1.84 | 1.28 | 2.25 | — | -22.8% |
| Diluted EPS | 1.42 | 1.84 | 1.28 | 2.25 | — | -22.8% |
| EBIT | $87.27M | $68.22M | $58.68M | $61.35M | — | +27.9% |
| EBITDA | $109.66M | $86.91M | $74.37M | $76.09M | — | +26.2% |
| Basic shares | 15.18M | 15.06M | 14.19M | 12.98M | — | +0.7% |
| Diluted shares | 15.18M | 15.06M | 14.19M | 12.98M | — | +0.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $35.57M | $41.36M | $152.82M | $31.59M | -14.0% |
| Cash & short-term investments | $35.57M | $41.36M | $152.82M | $31.59M | -14.0% |
| Accounts receivable | $64.25M | $59.04M | $51.87M | $68.61M | +8.8% |
| Total current assets | $139.99M | $137.58M | $233.38M | $111.27M | +1.7% |
| Property, plant & equipment | $179.85M | $166.08M | $129.53M | $127.75M | +8.3% |
| Goodwill & intangibles | $865.25M | $846.46M | $619.25M | $602.86M | +2.2% |
| Total assets | $1.20B | $1.17B | $997.24M | $858.15M | +3.1% |
| Total current liabilities | $139.04M | $116.28M | $102.19M | $85.49M | +19.6% |
| Current debt | $9.87M | $11.00M | $7.69M | $7.86M | -10.3% |
| Long-term debt | $152.59M | $142.53M | $138.99M | $175.83M | +7.1% |
| Total debt | $315.17M | $295.23M | $258.59M | $295.34M | +6.8% |
| Total liabilities | $433.81M | $408.42M | $345.00M | $373.59M | +6.2% |
| Retained earnings | $227.22M | $227.26M | $223.77M | $232.95M | -0.0% |
| Shareholder equity | $476.43M | $488.93M | $476.19M | $315.79M | -2.6% |
| Working capital | $950.00K | $21.30M | $131.19M | $25.78M | -95.5% |
| Net tangible assets | -$388.82M | -$357.53M | -$143.06M | -$287.06M | -8.8% |
| Shares issued | 17.42M | 17.31M | 17.20M | 15.22M | +0.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $58.01M | $45.60M | $37.22M | $43.41M | +27.2% |
| Depreciation & amortisation | $22.39M | $18.68M | $15.70M | $14.74M | +19.9% |
| Stock-based compensation | $8.27M | $7.82M | $7.24M | $7.26M | +5.7% |
| Change in working capital | -$27.19M | -$12.40M | -$4.93M | -$21.73M | -119.2% |
| Operating cash flow | $75.06M | $74.94M | $81.98M | $58.54M | +0.2% |
| Capital expenditure | -$14.07M | -$9.19M | -$9.29M | -$8.25M | -53.2% |
| Investing cash flow | -$36.71M | -$149.45M | -$45.02M | -$81.27M | +75.4% |
| Share buybacks | -$5.57M | $0 | $0 | — | — |
| Dividends paid | -$27.36M | -$26.54M | -$24.13M | -$21.32M | -3.1% |
| Financing cash flow | -$44.14M | -$36.95M | $84.27M | $25.76M | -19.4% |
| Free cash flow | $60.99M | $65.75M | $72.68M | $50.29M | -7.2% |
| End cash position | $35.57M | $41.36M | $152.82M | $31.59M | -14.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $214.06M | $198.29M | $202.73M | $197.13M | $197.34M | +8.0% |
| Operating revenue | $178.79M | $164.33M | $169.68M | $164.02M | $164.18M | +8.8% |
| Cost of revenue | $172.12M | $165.53M | $162.59M | $160.26M | $155.72M | +4.0% |
| Gross profit | $41.94M | $32.75M | $40.13M | $36.87M | $41.62M | +28.1% |
| Total operating expense | $19.00M | $18.27M | $18.13M | $17.41M | $17.48M | +4.0% |
| Operating income | $22.94M | $14.48M | $22.01M | $19.46M | $24.15M | +58.4% |
| Net interest income | -$3.18M | -$2.77M | -$2.33M | -$2.38M | -$2.39M | -14.7% |
| Pre-tax income | $19.05M | $10.56M | $14.96M | $22.88M | $22.65M | +80.4% |
| Tax provision | $4.16M | $2.41M | $5.78M | $5.23M | $4.93M | +72.6% |
| Net income | $1.60M | -$4.33M | -$10.55M | $5.22M | $7.59M | +137.0% |
| Net income to common | $3.81M | -$1.84M | -$6.55M | $7.24M | $8.81M | +306.4% |
| Basic EPS | 0.25 | -0.12 | -0.44 | 0.48 | 0.58 | +308.3% |
| Diluted EPS | 0.25 | -0.12 | -0.44 | 0.48 | 0.58 | +308.3% |
| EBIT | $22.27M | $13.35M | $17.31M | $25.28M | $25.07M | +66.7% |
| EBITDA | $28.20M | $19.35M | $21.94M | $31.11M | $31.13M | +45.7% |
| Basic shares | 15.07M | 15.17M | 15.17M | 15.20M | 15.20M | -0.6% |
| Diluted shares | 15.07M | 15.17M | 15.17M | 15.20M | 15.20M | -0.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $24.89M | $28.44M | $35.57M | $31.10M | $34.09M | -12.5% |
| Cash & short-term investments | $24.89M | $28.44M | $35.57M | $31.10M | $34.09M | -12.5% |
| Accounts receivable | $69.60M | $69.08M | $64.25M | $67.63M | $65.96M | +0.8% |
| Total current assets | $139.68M | $139.11M | $139.99M | $138.44M | $140.53M | +0.4% |
| Property, plant & equipment | $196.90M | $187.82M | $179.85M | $174.15M | $169.37M | +4.8% |
| Goodwill & intangibles | $893.08M | $895.69M | $865.25M | $866.84M | $853.22M | -0.3% |
| Total assets | $1.25B | $1.24B | $1.20B | $1.20B | $1.18B | +0.5% |
| Total current liabilities | $109.91M | $117.30M | $139.04M | $115.08M | $118.84M | -6.3% |
| Current debt | $4.56M | $10.80M | $9.87M | $8.80M | $8.17M | -57.8% |
| Long-term debt | $215.46M | $194.04M | $152.59M | $151.46M | $151.91M | +11.0% |
| Total debt | $385.79M | $362.83M | $315.17M | $308.40M | $305.40M | +6.3% |
| Total liabilities | $482.22M | $459.19M | $433.81M | $413.83M | $414.01M | +5.0% |
| Retained earnings | $213.36M | $216.88M | $227.22M | $237.27M | $236.36M | -1.6% |
| Shareholder equity | $448.66M | $468.98M | $476.43M | $503.57M | $500.75M | -4.3% |
| Working capital | $29.77M | $21.81M | $950.00K | $23.36M | $21.69M | +36.5% |
| Net tangible assets | -$444.43M | -$426.72M | -$388.82M | -$363.27M | -$352.47M | -4.1% |
| Shares issued | 14.92M | 17.53M | 17.42M | 17.42M | 17.42M | -14.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $14.90M | $8.16M | $9.18M | $17.64M | $17.72M | +82.7% |
| Depreciation & amortisation | $5.93M | $6.00M | $4.63M | $5.83M | $6.06M | -1.1% |
| Stock-based compensation | $3.17M | $2.31M | $2.12M | $2.26M | $2.12M | +37.2% |
| Change in working capital | $5.12M | -$19.43M | $2.13M | -$6.27M | $5.25M | +126.4% |
| Operating cash flow | $34.37M | $3.81M | $24.93M | $19.94M | $34.86M | +802.6% |
| Capital expenditure | -$5.36M | -$5.37M | -$3.93M | -$4.32M | -$3.25M | +0.2% |
| Investing cash flow | -$6.41M | -$39.80M | -$5.44M | -$11.94M | -$12.71M | +83.9% |
| Dividends paid | — | — | -$6.84M | -$6.84M | — | — |
| Financing cash flow | -$31.52M | $28.86M | -$15.02M | -$10.99M | -$27.25M | -209.2% |
| Free cash flow | $29.01M | -$1.56M | $21.01M | $15.63M | $31.61M | +1,953.4% |
| End cash position | $24.89M | $28.44M | $35.57M | $31.10M | $34.09M | -12.5% |
Options analytics
Put / call volume
0.30
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
70.00
-16.3% from spot
ATM implied vol
3.1%
Nearest strike to spot
Skew (10% OTM)
-6.2%
Calls bid over puts
Call volume
192
Contracts, this expiry
Put volume
58
Contracts, this expiry
Heaviest call OI
80.00
0 contracts
Heaviest put OI
70.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.84 | 0.75 | -11.1% |
| Mar 2026 | 0.52 | 0.46 | -11.0% |
| Dec 2025 | 0.67 | 0.67 | -0.6% |
| Sep 2025 | 0.66 | 0.66 | +0.1% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.73 | 6 | $214.54M | +8.8% |
| Next quarter | 0.91 | 6 | $220.97M | +9.0% |
| Current year | 2.90 | 5 | $847.89M | +8.6% |
| Next year | 3.35 | 6 | $912.01M | +7.6% |
Analyst targets & ownership
Mean target$97.00
High target$100.00
Low target$95.00
Implied upside16.87%
Analyst count6
ConsensusNONE
Strong buy / Buy4 / 2
Hold1
Sell / Strong sell0 / 0
Held by insiders2.54%
Held by institutions111.16%
Institutions holding323
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
84.31
-1.56% from price
SMA 20
82.71
+1.11% from price
SMA 50
80.46
+3.95% from price
SMA 100
73.85
+12.40% from price
SMA 200
76.33
+9.56% from price
EMA 12
83.65
-0.77% from price
EMA 26
82.24
+0.92% from price
EMA 50
80.01
+3.73% from price
RSI (14)
56.5
Neutral
MACD (12,26,9)
1.40
Hist -0.15
ATR (14)
2.18
2.60% of price
Realised vol 30D
18.8%
Annualised
Bollinger upper
87.46
20, 2σ
Bollinger lower
77.97
20, 2σ
50 / 200 cross
Golden
80.46 vs 76.33
Trend bias
Above 200
+9.56%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.62
Less volatile than market
Correlation to SPY
0.21
Largely independent
Realised vol 30D
18.8%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-36.7%
Peak to trough
Max drawdown 5Y
-54.7%
Peak to trough
ATR 14
2.18
2.60% of price
Beta (reported)
1.11
5Y monthly, from filing
Short interest
Shares short
1.29M
Prior 1.27M
Change vs prior
+1.8%
Shorts adding
% of float
10.37%
Elevated
% of shares out
8.67%
Against total outstanding
Days to cover
8.1
Crowded exit
Float
14.54M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 11, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Aug 10, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| Jun 24, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| May 13, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| May 8, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| Feb 20, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| Jan 5, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| Nov 24, 25 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Oct 24, 25 | Barrington Research | MAINTAINED | Outperform | Outperform |
| Aug 8, 25 | Barrington Research | MAINTAINED | Outperform | Outperform |
| Jul 1, 25 | Barrington Research | MAINTAINED | Outperform | Outperform |
| Apr 22, 25 | JMP Securities | MAINTAINED | Market Outperform | Market Outperform |
Dividends & splits
Forward rate$1.84 / yr
Forward yield2.20%
5-year avg yield1.85%
Payout ratio1011.11%
Ex-dividend dateAug 21, 2026
Next pay dateSep 11, 2026
Last split3:2
Split dateJun 29, 2001
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-28
Corporate Changes & Voting Matters
8-K · 2026-09-21
Corporate Changes & Voting Matters
8-K · 2026-08-14
Corporate Changes & Voting Matters
8-K · 2026-08-12
Corporate Changes & Voting Matters
8-K · 2026-08-10
Periodic Financial Reports
10-Q · 2026-08-07
Corporate Changes & Voting Matters
8-K · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-07-06
Headlines
Why Concentra’s Quiet Healthcare Business Keeps Winning
MarketBeat · 5d ago
3 Cash-Producing Stocks with Questionable Fundamentals
StockStory · 7d ago
U.S. Physical Therapy Announces the Appointment of New Board Member Myra Davis
Business Wire · 16d ago
U.S. Physical Therapy (USPH), What Is Drawing Fresh Attention Now?
Simply Wall St. · 16d ago
Will a New CFO and Tighter Cash Flow Lens Change U.S. Physical Therapy's (USPH) Narrative
Simply Wall St. · 16d ago
U.S. Physical Therapy (USPH) Stock Could Be 44% Undervalued After CFO Appointment
Simply Wall St. · 16d ago
US Physical Therapy (USPH) Taps A Global Finance Veteran As CFO
Insider Monkey · 23d ago
U.S. Physical Therapy Bets on Hospital Alliances to Drive Visits, Reimbursement
MarketBeat · 41d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.